On a different level: telavancin versus vancomycin for hospital-acquired pneumonia. - Suppr | 超能文献

On a different level: telavancin versus vancomycin for hospital-acquired pneumonia.

作者信息

Tarchini Giorgio

出版信息

Clin Infect Dis. 2011 Jun;52(11):1390; author reply 1391-2. doi: 10.1093/cid/cir189.

DOI:10.1093/cid/cir189

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

On a different level: telavancin versus vancomycin for hospital-acquired pneumonia.

Clin Infect Dis. 2011 Jun;52(11):1390; author reply 1391-2. doi: 10.1093/cid/cir189.

2

Pharmacodynamics, pharmacokinetics and clinical efficacy of telavancin in the treatment of pneumonia.替加环素治疗肺炎的药效学、药代动力学及临床疗效

Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):803-12. doi: 10.1080/17425255.2016.1187599. Epub 2016 May 30.

3

Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.替考拉宁与万古霉素治疗菌血症型医院获得性肺炎的比较

Int J Antimicrob Agents. 2013 Oct;42(4):367-9. doi: 10.1016/j.ijantimicag.2013.06.003. Epub 2013 Jul 26.

4

Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality.替拉万星治疗医院获得性肺炎临床试验：革兰氏阴性菌感染和革兰氏阴性菌覆盖不充分对临床疗效和全因死亡率的影响。

Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S87-93. doi: 10.1093/cid/civ536.

5

Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies.替拉万星治疗医院获得性肺炎：ATTAIN 研究结果。

Expert Rev Anti Infect Ther. 2012 Aug;10(8):847-54. doi: 10.1586/eri.12.81.

6

The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia.ATTAIN试验：替考拉宁与万古霉素治疗医院获得性和呼吸机相关性细菌性肺炎的疗效与安全性比较

Future Microbiol. 2014;9(3):281-9. doi: 10.2217/fmb.14.4. Epub 2014 Jan 22.

7

The clinical positioning of telavancin in Europe.在欧洲，替考拉宁的临床定位。

Int J Antimicrob Agents. 2015 Mar;45(3):213-20. doi: 10.1016/j.ijantimicag.2014.12.006. Epub 2014 Dec 24.

8

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.替拉万星与万古霉素治疗革兰阳性菌所致医院获得性肺炎。

Clin Infect Dis. 2011 Jan 1;52(1):31-40. doi: 10.1093/cid/ciq031.

9

The role of telavancin in hospital-acquired pneumonia and ventilator-associated pneumonia.替考拉宁在医院获得性肺炎和呼吸机相关性肺炎中的作用。

Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S79-86. doi: 10.1093/cid/civ535.

10

Telavancin (Vibativ) for gram-positive skin infections.

Med Lett Drugs Ther. 2010 Jan 11;52(1329):1-2.

引用本文的文献

1

Systematic Review and Meta-Analysis of the Efficacy and Safety of Telavancin for Treatment of Infectious Disease: Are We Clearer?替加环素治疗传染病疗效与安全性的系统评价和Meta分析：我们更清楚了吗？

Front Pharmacol. 2016 Sep 23;7:330. doi: 10.3389/fphar.2016.00330. eCollection 2016.

2

Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis.替拉万星在临床试验中的疗效和安全性：系统评价和荟萃分析。

PLoS One. 2012;7(8):e41870. doi: 10.1371/journal.pone.0041870. Epub 2012 Aug 16.